Dual cardiac contractile effects of the α2-AMPK deletion in low-flow ischemia and reperfusion

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 6, 2007, Pages

  Carvajal, Karla ^a   Zarrinpashneh, Elham ^b   Szarszoi, Ondrej ^a   Joubert, Frederic ^a   Athea, Yoni ^a   Mateo, Philippe ^a   Gillet, Brigitte ^c   Vaulont, Sophie ^d   Viollet, Benoit ^d   Bigard, Xavier ^e   Bertrand, Luc ^b   Ventura Clapier, Renée ^a   Hoerter, Jacqueline A ^a  

^a Universite Paris Sud   (France)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c CNRS   (France)

^d INSTITUT COCHIN   (France)

^e Centre Recherche Service Santé Armée   (France)

Author keywords

31p nmr spectroscopy; Creatine kinase; Energetic cost of contractility; Energetics; Fatty acids; Glucose uptake; Pyruvate; Rigor

Indexed keywords

CREATINE KINASE; FATTY ACID; GLUCOSE; GLYCOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING; ENERGY TRANSFER; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE DELETION; GLUCOSE TRANSPORT; GLYCOGEN ANALYSIS; HEART FUNCTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HIGH ENERGY PHOSPHATE; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REPERFUSION INJURY; WILD TYPE;

EID: 34447513872     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00683.2006     Document Type: Article

References (53)

1. 1-subunit AMP allosteric regulatory site. Protein Sci 13: 155-165, 2004.
2. Altarejos JY, Taniguchi M, Clanachan AS, Lopaschuk GD. Myocardial ischemia differentially regulates LKB1 and an alternate 5′ AMP-activated protein kinase kinase. J Biol Chem 280: 183-190, 2004.
3. Athea Y, Veksler V, Viollet B, Garnier A, Vaulont S, Ventura-Clapier R. Knock out of the α2 subunit of AMP activated protein kinase (AMPK) alters cardiac oxidative capacity and substrate utilization (Abstract). Circulation 108: 296, 2003.
4. 2 deficiency affects cardiac cardiolipin homeostasis and mitochondrial function. Diabetes 56; 786-794, 2007.
5. Balschi JA, Shen H, Madden MC, Hai JO, Bradley EL, Wolkowicz PE. Model systems for modulating the free energy of ATP hydrolysis in normoxically perfused rat hearts. Mol Cell Cardiol 29: 3123-3133, 1997.
6. Bassenge E, Sommer O, Schwemmer M, Bunger R. Antioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state. Am J Physiol Heart Circ Physiol 279: H2431-H2438, 2000.
7. 31P NMR magnetization transfer study. J Biol Chem 260: 3512-3517, 1985.
8. Burkhoff D, Weiss RG, Schulman SP, Kalil R, Wannenburg T, Gerstenblith G. Influence of metabolic substrate on rat heart function and metabolism at different coronary flows. Am J Physiol Heart Circ Physiol 261: H741-H750, 1991.
9. Cave C, Ingwall JS, Friedrich J, Liao RL, Saupe KW, Apstein CS, Eberli FR. ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation 101: 2090-2096, 2000.
10. Chen WN, Hoerter JA, Guéron. M. A comparison of AMP degradation in the perfused rat heart during 2-deoxy-D-glucose perfusion and anoxia. 1. The release of adenosine and inosine. J Mol Cell Cardiol 28: 2163-2174, 1996.
11. Christian TF, O'Connor MK, Schwartz RS, Gibbons RJ, Ritman EL. Technetium-99m MIBI to assess coronary collateral flow during acute myocardial infarction in two closed-chest animal models. J Nucl Med 38: 1840-1846, 1997.
12. Clark H, Carling D, Saggerson D. Covalent activation of heart AMPactivated protein kinase in response to physiological concentrations of long-chain fatty acids. Eur J Biochem 271: 2215-2224, 2004.
13. Cross HR, Opie LH, Radda GK, Clarke K. Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved. Circ Res 78: 482-491, 1996.
14. 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome. J Biol Chem 277: 51017-51024, 2002.
15. Dyck JR, Lopaschuk GD. AMPK alterations in cardiac physiology and pathology: enemy or ally? J Physiol 574: 95-112, 2006.
16. Folmes CD, Clanachan AS, Lopaschuk GD. Fatty acids attenuate insulin regulation of 5′-AMP-activated protein kinase and insulin cardioprotection after ischemia. Circ Res 99: 61-68, 2006.
17. Frederich M, Balschi JA. The relationship between AMP-activated protein kinase activity and AMP concentration in the isolated perfused rat heart. J Biol Chem 277: 1928-1932, 2002.
18. Frederich M, Zhang L, Balschi JA. Hypoxia and AMP independently regulate AMP-activated protein kinase activity in the heart. Am J Physiol Heart Circ Physiol 288: H2412-H2421, 2005.
19. Gustafson LA, Zuurbier CJ, Bassett JE, Barends JP, Van Beek JH, Bassingthwaighte JB, Kroll K. Increased hypoxic stress decreases AMP hydrolysis in rabbit heart. Cardiovasc Res 44: 333-343, 1999.
20. Headrick JP, Emerson CS, Berr SS, Berne RM, Matherne GP. Interstitial adenosine and cellular metabolism during beta-adrenergic stimulation of the in situ rabbit heart. Cardiovasc Res 31: 699-710, 1996.
21. Headrick JP, Peart J, Hack B, Flood A, Matherne GP. Functional properties and responses to ischaemia-reperfusion in Langendorff perfused mouse heart. Exp Physiol 86: 703-716, 2001.
22. 31P-NMR study. Am J Physiol Cell Physiol 255: C192-C201, 1988.
23. 31P NMR detection of subcellular creatine kinase fluxes in the perfused rat heart. Contractility modifies energy transfer pathways. J Biol Chem 277: 18469-18476, 2002.
24. Kolocassides KG, Galinanes M, Hearse DJ. Dichotomy of ischemic preconditioning: improved postischemic contractile function despite intensification of ischemic contracture. Circulation 93: 1725-1733, 1996.
25. Kolocassides KG, Seymour AML, Galinanes M, Hearse DJ. Paradoxical effect of ischemic preconditioning on ischemic contracture? NMR studies of energy metabolism and intracellular pH in the rat heart. J Mol Cell Cardiol 28: 1045-1057, 1996.
26. Korvald C, Elvenes OP, Myrmel T. Myocardial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol Heart Circ Physiol 278: H1345-H1351, 2000.
27. Kovacic S, Soltys CL, Barr AJ, Shiojima I, Walsh K, Dyck JR. Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J Biol Chem 278: 39422-39427, 2003.
28. Kroll K, Kinzie DJ, Gustafson LA. Open-system kinetics of myocardial phosphoenergetics during coronary underperfusion. Am J Physiol Heart Circ Physiol 272: H2563-H2576, 1997.
29. Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5′-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J Biol Chem 270: 17513-17520, 1995.
30. Kudo N, Gillespie JG, Kung L, Witters LA, Schulz R, Clanachan AS, Lopaschuk GD. Characterization of 5′AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biophys Biochim Acta 1301: 67-75, 1996.
31. 2+ on the Keq of the creatine kinase reaction and other phosphate hydrolyses and phosphate transfer reactions. J Biol Chem 254: 6528-6537, 1979.
32. Leon H, Atkinson LL, Sawicka J, Strynadka K, Lopaschuk GD, Schulz R. Pyruvate prevents cardiac dysfunction and AMP-activated protein kinase activation by hydrogen peroxide in isolated rat hearts. Can J Physiol Pharmacol 82: 409-416, 2004.
33. Lloyd SG, Wang P, Zeng H, Chatham JC. The impact of low-flow ischemia on substrate oxidation and glycolysis in the isolated perfused rat heart. Am J Physiol Heart Circ Physiol 287: H351-H362, 2004.
34. Mallet RT, Sun J. Mitochondrial metabolism of pyruvate is required for its enhancement of cardiac function and energetics. Cardiovasc Res 42: 149-161, 1999.
35. Momken I, Lechene P, Koulmann N, Fortin D, Mateo Doan BT P, Hoerter JA, Bigard X, Veksler V, Ventura-Clapier R. Impaired voluntary running capacity of creatine kinase-deficient mice. J Physiol 565: 951-964, 2005.
36. Neely JR, Grotyohann LW. Role of glycolytic products in damage to ischemic myocardium. Dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts. Circ Res 55: 816-824, 1984.
37. Ponticos M, Lu QL, Morgan JE, Hardie DG, Partridge TA, Carling D. Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. EMBO J 17: 1688-1699, 1998.
38. Pucar D, Bast P, Gumina R, Lim L, Drahl C, Juranic N, Macura S, Janssen E, Wieringa B, Terzic A, Dzeja PP. Adenylate kinase AK1 knockout heart: energetics and functional performance under ischemiareperfusion. Am J Physiol Heart Circ Physiol 283: H776-H782, 2002.
39. Russell RR III, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ, Young LH. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 114: 495-503, 2004.
40. Sambandam N, Lopaschuk GD. AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart. Prog Lipid Res 42: 238-256, 2003.
41. Sanders MJ, Grondin PO, Hegarty BD, Snowden MA, Carling D. Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade. Biochem J 403: 139-148, 2007.
42. Schwartz K, Boheler KR, Delabastie D, Lompre AM, Mercadier JJ. Switches in cardiac muscle gene expression as a result of pressure and volume overload. Am J Physiol Regul Integr Comp Physiol 262: R364-R369, 1992.
43. Skladanowski AC, Newby AC. Partial purification and properties of an AMP-specific soluble 5′-nucleotidase from pigeon heart. Biochem J 268: 117-122, 1990.
44. Soboll S, Bunger R. Compartmentation of adenine nucleotides in the isolated working guinea pig heart stimulated by noradrenaline. Hoppe Seylers Z Physiol Chem 36: 125-132, 1981.
45. Stein SC, Woods A, Jones NA, Davison MD, Carling D. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 345: 437-443, 2000.
46. Stepanov V, Mateo P, Gillet B, Beloeil JC, Lechene P, Hoerter JA. Kinetics of creatine kinase in an experimental model of low phosphocreatine and ATP in the normoxic heart. Am J Physiol Cell Physiol 273: C1397-C1408, 1997.
47. Ventura-Clapier R, Vassort G. Role of myofibrillar creatine kinase in the relaxation of rigor tension in skinned cardiac muscle. Pflügers Arch 404: 157-161, 1985.
48. Ventura-Clapier R, Veksler V. Myocardial ischemic contracture. Metabolites affect rigor tension development and stiffness. Circ Res 74: 920-929, 1994.
49. Ventura-Clapier R, Veksler V, Hoerter JA. Myofibrillar creatine kinase and cardiac contraction. Mol Cell Biochem 133: 125-144, 1994.
50. 2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 111: 91-98, 2003.
51. 2 subunit of AMP-activated protein kinase. J Biol Chem 278: 28372-28377, 2003.
52. Young LH, Li J, Baron SJ, Russell RR. AMP-activated protein kinase: a key stress signaling pathway in the heart. Trends Cardiovasc Med 15: 110-8, 2005.
53. 2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia. Am J Physiol Heart Circ Physiol 291: H2875-H2883, 2006.